Accumulating evidence has revealed that the aberrant expression of CS synthases and CS modification enzymes along with increased CSPGs in the tumor microenvironment are characteristic hallmarks of several types of cancer, including glioma [17,39,40,41,42,43,44]. This evidence concerns the gene CS and central nervous system cancer.